Susquehanna International Group, LLP Personalis, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 14, 2025	BUY	$3.0 - $6.57 $200,400 - $438,876	66,800 Added 414.91%	82,900 $543,000
Q1 2025 May 14, 2025	BUY	$3.51 - $6.64 $56,511 - $106,904	16,100 New	16,100 $56,000
Q3 2024 Nov 14, 2024	BUY	$1.19 - $6.34 $12,614 - $67,204	10,600 New	10,600 $57,000
Q4 2021 Feb 14, 2022	SELL	$12.24 - $21.25 $122,400 - $212,500	-10,000 Reduced 43.86%	12,800 $183,000
Q2 2021 Aug 11, 2021	BUY	$18.15 - $27.75 $99,824 - $152,625	5,500 Added 31.79%	22,800 $577,000
Q1 2021 May 17, 2021	SELL	$20.71 - $51.02 $209,171 - $515,302	-10,100 Reduced 36.86%	17,300 $426,000
Q4 2020 Feb 16, 2021	SELL	$21.84 - $44.0 $487,032 - $981,200	-22,300 Reduced 44.87%	27,400 $1 Million
Q3 2020 Nov 16, 2020	BUY	$13.63 - $24.12 $677,411 - $1.2 Million	49,700 New	49,700 $1.08 Million

111

36.6M

82.9K

74.1K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $377M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.